Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 414

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

An In vivo Platform for Translational Drug Development in Pancreatic Cancer

Open access
Rubio-Viqueira, Belen, Jimeno, Antonio, Cusatis, George, Zhang, Xianfeng, Iacobuzio-Donahue, Christine, Karikari, Collins, Shi, Chanjusn, Danenberg, Kathleen, Danenberg, Peter V., Kuramochi, Hidekazu, Tanaka, Koji, Singh, Sharat, Salimi-Moosavi, Hossein, Bouraoud, Nadia, Amador, Maria L., Altiok, Soner, Kulesza, Piotr, Yeo, Charles, Messersmith, Wells, Eshleman, James, Hruban, Ralph H., Maitra, Anirban, Hidalgo, Manuel·2006·Clinical Cancer Research

Abstract

Effective development of targeted anticancer agents includes the definition of the optimal biological dose and biomarkers of drug activity. Currently available preclinical models are not optimal to this end. We aimed at generating a model for translational drug development using pancreatic cancer as a prototype. Resected pancreatic cancers from 14 patients were xenografted and expanded in successive groups of nude mice to develop cohorts of tumor-bearing mice suitable for drug therapy in simulated early clinical trials. The xenografted tumors maintain their fundamental genotypic features despite serial passages and recapitulate the genetic heterogeneity of pancreatic cancer. The in vivo platform is useful for integrating drug screening with biomarker discovery. Passages of tumors in successive cohorts of mice do not change their susceptibility to anticancer agents and represent a perpetual live bank, facilitating the application of new technologies that will result in the creation of an integrated stable database of tumor-drug response data and biomarkers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-06-0113

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 414

Metadata

Authors
Rubio-Viqueira, B., Jimeno, A., Cusatis, G., Zhang, X., Iacobuzio-Donahue, C., Karikari, C., Shi, C., Danenberg, K., Danenberg, P. V., Kuramochi, H., Tanaka, K., Singh, S., Salimi-Moosavi, H., Bouraoud, N., Amador, M. L., Altiok, S., Kulesza, P., Yeo, C., Messersmith, W., Eshleman, J., Hruban, R. H., Maitra, A., & Hidalgo, M.
Venue
Clinical Cancer Research
Published
2006-08-01
Volume
12
Issue
15
Pages
4652-4661
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2172077519
Cited by
414
References
40
FWCI
5.89
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An In vivo Platform for Translational Drug Development in Pancreatic Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-06-0113
The paper
Rubio-Viqueira, B., Jimeno, A., Cusatis, G., Zhang, X., Iacobuzio-Donahue, C., Karikari, C., Shi, C., Danenberg, K., Danenberg, P. V., Kuramochi, H., Tanaka, K., Singh, S., Salimi-Moosavi, H., Bouraoud, N., Amador, M. L., Altiok, S., Kulesza, P., Yeo, C., Messersmith, W., . . . Hidalgo, M. (2006). An In vivo Platform for Translational Drug Development in Pancreatic Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-06-0113

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.